Related Experiment Videos
Targeting antigen to CD19 on B cells efficiently activates T cells
Jun Yan1, Martin J Wolff, Julia Unternaehrer
1Section of Rheumatology, Department of Internal Medicine, Ludwig Institute for Cancer Research, Yale University School of Medicine, 300 Cedar Street, S525, PO Box, 208031 New Haven, CT 06520-8031, USA.
International Immunology
|June 22, 2005
Summary
Targeting CD19 (a B cell protein) facilitates rapid antigen uptake and presentation, enhancing T cell activation. This offers a novel strategy for B lymphocyte targeting in immunology.
Area of Science:
- Immunology
- Cell Biology
Background:
- CD19 is a B cell-surface molecule crucial for regulating B cell signaling and differentiation upon antigen binding.
- CD19 functions in a complex with CD21, amplifying signals via Src family kinases.
Purpose of the Study:
- To investigate the kinetics of antigen uptake and processing when directly targeted to CD19 on B cells.
- To evaluate the impact of CD19-mediated antigen targeting on B cell co-stimulatory molecule expression and T cell activation.
Main Methods:
- Purified B cells were used to study antigen uptake and processing kinetics after direct targeting to CD19.
- In vivo studies involved intravenous administration of antigen-anti-CD19 complexes to assess B cell binding and T cell activation.
Main Results:
- Antigen internalized via CD19 is rapidly capped at the B cell surface within minutes and localized to lysosomes within 90 minutes.
- B cells engaging antigen through CD19 show increased expression of B7-1 and B7-2 co-stimulatory molecules.
- Intravenous administration of antigen-anti-CD19 complexes efficiently activates antigen-specific T cells in vivo, comparable to surface IgM-mediated uptake.
Conclusions:
- Direct targeting of CD19 provides an efficient mechanism for antigen internalization and processing by B cells.
- CD19-mediated antigen presentation enhances co-stimulatory molecule expression and promotes robust T cell activation.
- This pathway represents a significant, previously unrecognized method for targeting B lymphocytes for enhanced antigen presentation and CD4 T cell activation.